Integral Derivatives’s Thermo Fisher Scientific TMO Stock Holding History

Integral Derivatives’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.01M	Sell	4,900 -1,600	-25%	-$336K	0.02%	236
2017 Q4	$1.23M	Buy	6,500 +2,000	+44%	+$383K	0.02%	423
2017 Q3	$851K	Buy	4,500 +1,700	+61%	+$308K	0.02%	551
2017 Q2	$489K	Buy	+2,800	New	+$470K	0.01%	713
2015 Q2	–	Sell	-2,200	Closed	-$296K	–	1257
2015 Q1	$296K	Sell	2,200 -2,800	-56%	-$361K	0.01%	831
2014 Q4	$626K	Hold	5,000	–	–	0.01%	837
2014 Q3	$608K	Hold	5,000	–	–	0.01%	910
2014 Q2	$590K	Sell	5,000 -10,500	-68%	-$1.24M	0.01%	887
2014 Q1	$1.86M	Buy	+15,500	New	+$1.84M	0.04%	438

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Integral Derivatives's TMO Position: Q2 2015 in Review

Integral Derivatives sold out of Thermo Fisher Scientific (TMO) in Q2 2015, closing a stake of 3,836 shares — an estimated $500K sold.

Integral Derivatives first reported a position in TMO in Q1 2014 and held it in 5 quarters. The position peaked at $1.74M in Q1 2014. 974 funds tracked by Wall St. Rank hold TMO as of Q2 2015.

Integral Derivatives reported no remaining Thermo Fisher Scientific position as of Q2 2015 after selling out during the quarter.
Integral Derivatives sold 3,836 Thermo Fisher Scientific shares in Q2 2015, an estimated $500K.
Integral Derivatives first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 5 quarters.
Integral Derivatives's Thermo Fisher Scientific position peaked at $1.74M in Q1 2014.
974 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2015.

Based on Integral Derivatives's 13F filing for Q2 2015, filed 15 Jul 2015.